10.31
前日終値:
$10.25
開ける:
$10.44
24時間の取引高:
76,960
Relative Volume:
0.24
時価総額:
$638.84M
収益:
-
当期純損益:
-
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
-
1週間 パフォーマンス:
-23.52%
1か月 パフォーマンス:
+156.47%
6か月 パフォーマンス:
+0.00%
1年 パフォーマンス:
+0.00%
Zhengye Biotechnology Holding Ltd Stock (ZYBT) Company Profile
ZYBT を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
ZYBT
Zhengye Biotechnology Holding Ltd
|
10.31 | 638.84M | 0 | 0 | 0 | 0.00 |
![]()
ZTS
Zoetis Inc
|
159.27 | 70.23B | 9.29B | 2.52B | 2.28B | 5.57 |
![]()
HLN
Haleon Plc Adr
|
10.74 | 48.23B | 14.35B | 1.85B | 0 | 0.4023 |
![]()
TAK
Takeda Pharmaceutical Co Adr
|
14.36 | 48.22B | 30.08B | 710.16M | 4.45B | 0.2182 |
![]()
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.93 | 18.57B | 16.54B | -1.64B | 749.00M | -1.45 |
![]()
UTHR
United Therapeutics Corp
|
301.42 | 13.29B | 2.76B | 1.11B | 898.10M | 22.77 |
Zhengye Biotechnology Holding Ltd (ZYBT) 最新ニュース
The Alternative Data Center Stocks Nobody Is Watching Right Now - Energy & Capital
Why Meta Shares Are Trading Higher By Around 6%; Here Are 20 Stocks Moving Premarket - Benzinga
Tesla, Regeneron Among Market Cap Stock Movers on Wednesday - Investing.com Australia
Zhengye Biotechnology Holding Ltd Inc. (ZYBT) Price Performance: A Technical Analysis Perspective - investchronicle.com
Tesla, UnitedHealth Lead Market Cap Stock Movers on Wednesday By Investing.com - Investing.com South Africa
Zhengye Biotechnology Delays 20-F Filing - TipRanks
Spotify, Regeneron lead Tuesday’s market cap stock movers By Investing.com - Investing.com South Africa
Zhengye Biotechnology Holding Ltd (ZYBT) Surges 35% - Energy & Capital
Pre-market Movers: STSS, THRD, PTN, VRAX... - RTTNews
The Only Nuclear Stocks to Buy Today - Energy & Capital
Zhengye Biotechnology Holding Ltd (ZYBT): Why Shares Soared 34.91% in a Single Day - Energy & Capital
Understanding ZYBT stock ratios for better investment decisions - uspostnews.com
Navigating ZYBT Stock: Zhengye Biotechnology Holding Ltd Journey - investchronicle.com
Chinese Fire Up Their Most Powerful Nuclear Plant - Energy & Capital
If You’re Not Buying Oil Stocks Right Now, Then You Hate Money. - Energy & Capital
Gold Is The Place To Be... Or Is It? - Energy & Capital
Buy Oil NOW, Thank Me Later - Energy & Capital
A Closer Look At Zhengye Biotechnology Holding Limited's (NASDAQ:ZYBT) Uninspiring ROE - simplywall.st
Should We Be Cautious About Zhengye Biotechnology Holding Limited's (NASDAQ:ZYBT) ROE Of 6.9%? - Yahoo Finance
Zhengye Biotechnology Forms Joint Venture to Expand Poultry Vaccine Sales - TipRanks
Nvidia, Tesla Slide Among Mega-Cap Movers on Wednesday By Investing.com - Investing.com Canada
Pre-market Movers: OSRH, SURG, BLNE, HUMA, TNON… - RTTNews
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
Chewy, Bausch Health Companies And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session - Benzinga
Why GameStop Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket - Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
Kuke Music Holding Ltd ADR’s: Contrasting Stock Performances in a Volatile Market - investchronicle.com
Trump’s Only Solution to Low Energy Prices - Energy & Capital
Trump Vs. OPEC Round 2: The Great Oil Showdown of 2025 - Energy & Capital
3 E Network Technology Group Ltd’s Quiet Period Will End on February 17th (NASDAQ:MASK) - Defense World
Zhengye Biotechnology Holding Limited’s (NASDAQ:ZYBT) Quiet Period Set To Expire on February 17th - Defense World
Zhengye Biotech’s ‘pet-sized’ IPO leaves plenty of room for more fundraising - Bamboo Works
Zhengye Biotechnology Holding Limited Announces Full Exercise of Underwriters’ Over-Allotment Option - GlobeNewswire
Zhengye Biotechnology Holding Limited Announces Full Exercise of Underwriters' Over-Allotment Option - The Manila Times
Zhengye Biotechnology Holding Limited Announces Closing of Initial Public Offering - GlobeNewswire
ZYBT Stock Price and Chart — NASDAQ:ZYBT - TradingView
ZYBT IPO NewsChinese animal health company Zhengye Biotechnology prices US IPO at the $4 low end - Renaissance Capital
Chinese vaccine maker Zhengye Biotechnology prices IPO at $4 per share - MSN
Zhengye Biotechnology Holding Limited Announces Pricing of Initial Public Offering - GlobeNewswire
Zhengye Biotechnology Holding Limited (ZYBT) to Raise $7 Million in IPO - Defense World
Silver Depletion By 2050? What Will Happen To Tech? - Energy & Capital
ZYBT News Today | Why did Zhengye Biotechnology stock go down today? - MarketBeat
Chinese animal health company Zhengye Biotechnology ups share offering by 20% ahead of $7 million US IPO - renaissancecapital.com
Gold Mining Stocks ListUnearthing Opportunities in 2024 - Energy & Capital
Nvidia's Rise Points To Something Bigger - Energy & Capital
Electric Bike Stocks5 E-Bike Companies to Watch in 2024 - Energy & Capital
Why Does Elon's New Lithium Refinery Reek of the CCP? - Energy & Capital
Cotações de Ações Americanas (STOCKS) - Money Times
InvestorsHubNYSE, NASDAQ, AMEX, OTCBB, Pink Sheet Stock Message Boards, Stock Charts, Stock Quotes, Level II and Market News - Investors Hub
Zhengye Biotechnology Holding Ltd (ZYBT) 財務データ
Zhengye Biotechnology Holding Ltd (ZYBT) の財務データはありません。詳細については、他の銘柄を確認してください。
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):